Scailyte

Recent Finacing

Series A

Recent Raise

$8M

Scailyte operates ScaiVision, an AI platform that analyzes multimodal single-cell omics (RNA/TCR/BCR, proteomics) to discover clinical biomarkers, support IVD assay development, and inform oncology/immunology trials.